You have selected the Free membership level.
The price for membership is $0.00 now.
Membership expires after 7 Days.
Do you have a discount code? Click here to enter your discount code.
Any advisory or signal generated by TheChartguys.com is provided for educational purposes only. Any trades placed upon reliance on TheChartguys.com systems are taken at your own risk for your own account. Past performance is no guarantee of future results. While there is great potential for reward trading securities and options there is also substantial risk of loss in all trading. You must decide your own suitability to trade. Future trading results can never be guaranteed. This is not an offer to buy or sell futures, options or commodity interests.
TheChartGuys.com is not registered as an investment adviser with any federal or state regulatory agency. The information contained within this Web site, including e-mail transmissions, faxes, recorded voice messages, and any other associated messages/media (hereinafter collectively referred to as “Information”) is provided for informational and educational purposes only. The Information should not be construed as investment / trading advice and is not meant to be a solicitation or recommendation to buy, sell, or hold any securities mentioned. Membership to TheChartGuys LLC and its contents is granted at will, and may be revoked at anytime without cause. TheChartGuys LLC reserves the right to cancel all membership packages at their own discretion. All sales final with refunds granted at the discretion of TheChartGuys LLC.
SAFE HARBOR STATEMENT: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. This stock profile/advertisement or e-mail alert contains or incorporates by reference” forward-looking statements,” including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s)”, _forecast(s) _will,_ _estimate(s),_ “understand(s)” or that by statements indicating certain actions _may,_ _could,_ or _might_ occur and similar expressions which are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the & Companies profiled herein to differ materially from these forecasts and projections as indicated by such forward-looking statements. Statements that are not strictly historical are _forward-looking_ within the meaning of the Safe Harbor Clause of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements invoke risk and uncertainties that may cause the Company’s actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the Company’s product both domestically and abroad, the Company’s ability to continue to develop its market, the Company’s ability to obtain necessary financing, general economic conditions, and other factors that may be more fully described in the company’s literature and any periodic filings with the Securities and Exchange Commission. Everything listed here creates an inherent conflict of interest and readers are encouraged to do their own research. Certain statements contained herein are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, results from ongoing research and development as well as clinical studies, ability to reproduce study results in humans, failure to obtain regulatory approval for the Company’s products, if required, failure to develop a product based on the Company’s technology, failure of any such products to compete effectively with existing products, the inability to find a strategic partner or to consummate a relationship with a potential strategic partner on acceptable terms, and other factors discussed in filings made by the Company with the Securities and Exchange Commission.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
Username or Email